Novel oral anticoagulants: reversal agents efficacy compared
Novel oral anticoagulants including dabigatran, apixaban, and rivaroxaban have numerous advantages over warfarin, but with their shorter track record, the real-world relative efficacy of their reversal agents is poorly understood. In a meta-analysis of retrospective reviews comprising 1832 patients, the available reversal agents (4-factor prothrombin co…
Keep reading with a 7-day free trial
Subscribe to PulmCCM to keep reading this post and get 7 days of free access to the full post archives.